Skip to main content
Quest Diagnostics

Generalized Dermal Hypersensitivity Reaction Following Moderna COVID-19 Vaccination

Generalized dermal hypersensitivity reaction following Moderna COVID-19 vaccination

Authors: Myrdal CN, Culpepper KS, DuPont SL.

Dermatol Ther. 2021 Oct 21:e15173. doi: 10.1111/dth.15173. Online ahead of print

Specialties: Dermatology, Infectious Disease

Disclaimer: One or more of the authors of this publication were employed at the time by DermPath, a subsidiary of Quest Diagnostics.

Generalized dermal hypersensitivity reaction following Moderna COVID-19 vaccination

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.